Covid-19 Resource Center
During these turbulent times, finding information is hard. The Quadax Resource Center will help keep you up to date on the latest COVID-19 topics, including laboratory testing, supply needs and payor and billing changes affecting reimbursement.
COVID-19 Payer Updates
Quadax is dedicated to keeping our clients up-to-date on the billing, reporting, and procedural information specific to each payer as it pertains to COVID-19.
Recent Blog Posts
Rising Expenses, Delta Variant Threatens Revenue Recovery
Recovery of hospital revenue to pre-pandemic levels is at risk according to a recent report from consultants Kaufman Hall. Rising expenses and increasing COVID hospitalizations threaten to reverse gains from the latter half of 2020 and the first half of 2021. In the current and ongoing state of uncertainty, it will be important for hospitals to have clear and current visibility into financial performance. Read on to learn how revenue cycle resiliency will further help to ensure hospitals are maximizing revenue, especially as margins remain thin and expenses high.
COVID-19 Articles, Bulletins, Town Halls, Webinars
Date | Article | Source |
10/5/2021 | COVID-19 Update | |
10/4/2021 | FDA Authorizes Additional OTC Home Test to Increase Access to Rapid Testing for Consumers | |
10/4/2021 | Lab Alert: Ellume Issues Voluntary Recall of Specific Lots of Ellume COVID-19 Home Tests | |
9/29/2021 | New COVID-19 Vaccine Codes: September Update | |
9/24/2021 | CMS Will Pay for COVID-19 Booster Shots, Eligible Consumers Can Receive at No Cost | |
9/22/2021 | Lab Advisory: CDC Updates SARS-CoV-2 Variant Classifications | |
9/22/2021 | FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations | |
9/10/2021 | COVID-19 Update | |
9/10/2021 | HHS Announces the Availability of $25.5 Billion in COVID-19 Provider Funding | |
9/3/2021 | AMA Announces Update to COVID-19 Vaccine CPT Codes | |
9/2/2021 | Lab Advisory: Shortage of COVID-19 Rapid Tests May Increase Demand for Laboratory Testing | |
9/2/2021 | Provider Enrollment Activities Resume in October | |
9/1/2021 | FDA to Hold Advisory Committee Meeting to Discuss Pfizer-BioNTech’s Application for COVID-19 Booster | |
8/24/2021 | CMS Expands Medicare Payments for At-Home COVID-19 Vaccinations | |
8/23/2021 | FDA Approves First COVID-19 Vaccine | |
8/18/2021 | Joint Statement from HHS Public Health and Medical Experts on COVID-19 Booster Shots | |
8/9/2021 | UPDATE: Lab Advisory 8/9/21: SARS-CoV-2 Variant Classification Updates | |
8/6/2021 | Clinical Laboratory COVID-19 Response Call on Monday, August 23 at 3:00 PM ET | |
8/2/2021 | Lab Alert: Clarifications about the Retirement of the CDC 2019 Novel Coronavirus (2019-nCov) Real-Time RT-PCR Diagnostic Panel | |
8/2/2021 | Hospital Inpatient Prospective Payment System Final Rule Increases Payments to Treat COVID-19 and Improves Quality of Data Collection | |
7/30/2021 | Coronavirus (COVID-19) Update | |
7/21/2021 | Lab Alert: Changes to CDC RT-PCR for SARS-CoV-2 Testing | |
7/20/2021 | Lab Advisory: SARS-CoV-2 Variant Classification Updates | |
7/18/2021 | Lab Alert: FDA Revokes EUA for Curative SARS-CoV-2 Assay | |
7/15/2021 | Lab Advisory: CDC Updates Pooling Guidance and Overview of Testing for SARS-CoV-2 Web Pages | |
7/13/2021 | Revised fact sheets for the Johnson & Johnson (Janssen) COVID-19 Vaccine to include information pertaining to an observed increased risk of Guillain-Barré Syndrome (GBS) following vaccination. | |
7/8/2021 | COVID-19 Snapshot: Impact on the Medicare Population | |
7/8/2021 | COVID-19 Accelerated and Advance Payments: Updated FAQs. | |
7/6/2021 | Lab Advisory: SARS-CoV-2 Variants AY.1 and AY.2 Now Aggregated with Delta Variant B.1.617.2 | |
6/30/2021 | CDC Launches New COVID-19 Viral Testing Tool | |
6/29/2021 | Lab Update: SARS-CoV-2 Variant Classification Changes | |
6/17/2021 | CMS Infographic: Medicare Payment for COVID-19 Vaccination Administered in the Home | |
6/16/2021 | CDC Updates Guidance for Reporting SARS-CoV-2 Sequencing Results. | |
6/15/2021 | Coronavirus (COVID-19) Update | |
6/14/2021 | Lab Alert: Sodium Citrate Blood Specimen Collection Tubes in Short Supply | |
6/14/2021 | Lab Advisory: CDC Launches New COVID-19 Viral Testing Tool | |
6/10/2021 | CMS increase provider payment for in-home COVID-19 vaccinations | |
6/9/2021 | Biden Administration Continues Efforts to Increase Vaccinations by Bolstering Payments for At-Home COVID-19 Vaccinations for Medicare Beneficiaries | |
6/9/2021 | HHS Secretary Xavier Becerra to Insurers & Providers: COVID-19 Vaccines and Testing Must be Free for Patients | |
5/28/2021 | Lab Advisory: CDC Updates Testing Strategies for SARS-CoV-2 Web Page | |
5/25/2021 | Coronavirus (COVID-19) Update: May 25, 2021 | |
5/25/2021 | HHS to Dedicate $4.8 Billion from American Rescue Plan to COVID-19 Testing for the Uninsured | |
5/21/2021 | Coronavirus (COVID-19) Update: May 21, 2021 | |
5/20/2021 | Lab Advisory: CDC Updates NAATs and Self-Testing Web Pages | |
5/19/2021 | Antibody Testing Is Not Currently Recommended to Assess Immunity After COVID-19 Vaccination: FDA Safety Communication | |
5/18/2021 | CDC Updates Interim Guidance for Antigen Testing for SARS-CoV-2 | |
5/5/2021 | SARS-CoV-2 Variant Classifications and Definitions | |
5/3/2021 | HHS Launches New Reimbursement Program for COVID-19 Vaccine Administration Fees not Covered by Insurance | |
4/26/2021 | Time to Say Goodbye to Some Insurers’ Waivers for Covid Treatment Fees | |
4/21/2021 | FDA Continues Important Steps to Ensure Quality, Safety and Effectiveness of Authorized COVID-19 Vaccines | |
4/20/2021 | The FDA issued a pooling and serial testing amendment for many molecular diagnostic COVID-19 tests that had received an emergency use authorization (EUA) for testing individual samples. | |
4/16/2021 | Medicare FFS Claims: | |
4/15/2021 | Message from HHS-OIG Leadership on the COVID-19 Vaccination Program and Provider Compliance | |
4/6/2021 | The FDA issued an Emergency Use Authorization (EUA) to Symbiotica, Inc., for the COVID-19 Self-Collected Antibody Test System | |
4/2/2021 | HHS Secretary Xavier Becerra Announces Expansion of COVID-19 Vaccine Program to All Community Health Centers Across the Country | |
4/2/2021 | New web page posted: SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests for clinical laboratory staff and health care providers about the impact of viral mutations on COVID-19 molecular, antigen, and serology tests | |
4/1/2021 | Repayment of COVID-19 Accelerated and Advance Payments Began on March 30, 2021 | |
3/30/2021 | Updated Serology EUA COVID-19 Templates Available | |
3/30/2021 | New FDA web page - SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests - for clinical laboratory staff and health care providers about the impact of viral mutations on COVID-19 molecular tests | |
3/26/2021 | FDA issues emergency use authorization (EUA) to the Twist Bioscience Corporation for their SARS-CoV-2 NGS Assay | |
3/26/2021 | Lab Advisory: CDC Publishes New Web Page on Nucleic Acid Amplification Tests (NAATs) | |
3/22/2021 | Lab Update: CMS Posts FAQ for Reporting Sequencing Results for SARS-CoV-2 Variants | |
3/15/2021 | Medicare Payment Increase for COVID-19 Vaccine | |
3/13/2021 | Lab Alert: FDA Issues Letter about Potential False Results with Roche cobas SARS-CoV-2 & Influenza Test | |
3/9/2021 | Senate Passes $1.9 Trillion COVID-19 Bill; Several CAP-Backed Provisions Move Forward | |
3/9/2021 | FDA issued an Emergency Use Authorization (EUA) to Cue Health Inc. for its over-the-counter at-home diagnostic test for COVID-19. | |
3/9/2021 | Medicare Part B Payment for COVID-19 Vaccines and Certain Monoclonal Antibodies during the Public Health Emergency | |
3/5/2021 | COVID-19 Update: FDA Issues Authorization for First Molecular Non-Prescription, At-Home Test | |
3/4/2021 | COVID-19 Vaccine Administration: Insurance Coverage, MBI, & MSP | |
3/2/2021 | Lab Advisory: FDA Issues New Guidance for Evaluating Impact of Viral Mutations on COVID-19 Tests | |
3/2/2021 | COVID-19 Update: The agency issued an Emergency Use Authorization (EUA) to Quidel for its QuickVue At-Home COVID-19 Test for at-home use with a prescription | |
2/27/2021 | House Approves Large COVID-19 Relief Bill; Includes $7.5 Billion for Vaccine Distribution | |
2/26/2021 | Biden Administration Strengthens Requirements that Plans and Issuers Cover COVID-19 Diagnostic Testing Without Cost Sharing and Ensures Providers are Reimbursed for Administering COVID-19 Vaccines to Uninsured | |
2/26/2021 | ACLA Statement on President Biden’s Actions to Close Coverage Gaps for COVID-19 Testing | |
2/12/2021 | COVID-19 Update: The FDA revised its guidance, Investigational COVID-19 Convalescent Plasma and associated web page, to reflect the reissued Emergency Use Authorization for COVID-19 convalescent plasma | |
2/11/2021 | COVID-19: Revised Clinician Codes Accepted with CS Modifier | |
2/3/2021 | COVID-19 Claims Reimbursement Program Update for the Uninsured | |
2/2/2021 | Lab Advisory: CDC Publishes New Web Pages on Genomic Surveillance for SARS-CoV-2 Variants | |
1/29/2021 | COVID-19 Update: The FDA has added content to the Q&A appendix in “Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency" | |
1/28/2021 | HHS Announces Marketplace Special Enrollment Period for COVID-19 Public Health Emergency | |
1/21/2021 | ACLA Statement on President Biden's Actions to Combat COVID-19 | |
1/19/2021 | Find your COVID-19 Vaccine CPT® Codes | |
1/8/2021 | FDA Issues Alert Regarding SARS-CoV-2 Viral Mutation to Health Care Providers and Clinical Laboratory Staff | |
1/8/2021 | Coronavirus (COVID-19) Update: January 8, 2021 | |
1/4/2021 | New ICD-10-CM code for the | |
12/22/2020 | Coronavirus (COVID-19) Update: December 22, 2020 | |
12/19/2020 | CMS Updates FAQs for CLIA Guidance during the COVID-19 Public Health Emergency | |
12/15/2020 | FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine | |
12/15/2020 | FDA Authorizes Antigen Test as First Over-the-Counter Fully At-Home Diagnostic Test for COVID-19 | |
12/11/2020 | COVID-19 and in vitro diagnostics: New market forces at play | |
12/10/2020 | CMS offers guidance in billing Medicare for COVID-19 antibody treatment | |
12/10/2020 | FAQs–Application of OIG's Administrative Enforcement Authorities to Arrangements Directly Connected to the Coronavirus Disease 2019 (COVID-19) Public Health Emergency | |
12/7/2020 | Lab Advisory: CMS Revises Enforcement Discretion for SARS-CoV-2 Point-of-Care Tests | |
12/5/2020 | Lab Update: CDC Updates SARS-CoV-2 Antigen Testing Guidance | |
12/3/2020 | Lab Update: CDC Offers New COVID-19 Specimen Collection Infographics | |
12/4/2020 | 13 insurers extending COVID-19 cost-sharing waivers into 2021 | |
12/3/2020 | COVID-19 Frequently Asked Questions (FAQs) on Medicare Fee-for-Service (FFS) Billing | |
12/1/2020 | Job Aids for Laboratory Professionals | |
12/1/2020 | Clinical Laboratory COVID-19 Response Calls | |
11/24/2020 | Guidance for SARS-CoV-2 Point-of-Care Testing | |
11/24/2020 | Pathologists Advocate for Higher COVID-19 Payments During AMA Meeting | |
11/24/2020 | A Closer Look at COVID-19 Diagnostic Testing | |
11/23/2020 | 2020 Clinical Lab & Pathology Resources | |
11/19/2020 | HHS Launches Pilot Program of Fast Molecular POC Test for COVID-19 | |
11/18/2020 | Virtual Town Hall Series - Coronavirus (COVID-19) Test Development and Validation | |
11/18/2020 | The FDA issued an EUA for the first COVID-19 diagnostic test for self-testing at home that provides rapid results | |
11/18/2020 | The FDA published a new "FDA Insight" podcast titled: "Personal Protective Equipment and COVID-19" | |
11/17/2020 | CAP Members Call on Congress to Stop Medicare Cuts | |
11/17/2020 | CAP Asks CMS to Reduce COVID-19 Laboratory Reporting Burdens, Increase Testing Resources | |
11/11/2020 | CMS Details Medicare Payment for New COVID-19 Antibody Drug | |
11/10/2020 | AMA Announces Vaccine-Specific CPT Codes for COVID-19 Immunizations | |
11/9/2020 | The FDA issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients | |
11/2/2020 | Clinical Laboratories Need Creative Staffing Strategies to Keep and Attract Hard-to-Find Medical Technologists, as Demand for COVID-19 Testing Increases |
